New antibiotic shows promise in fighting tuberculosis

Preliminary findings from the phase 1B PanACEA trial shows promising results for a

new antibiotic, BTZ-043. The aim is to create an antibiotic that can treat MDR-TB. So

far, the trial has shown antibacterial efficacy in a cohort of 77 individuals with newly

diagnosed pulmonary TB. Read more here.

Recent Posts

Despite trials like TB-PRACTECAL displaying the efficacy of pretomanid in the expanded BPaLM regimen, the EMA only approved for the BPaL...

The meeting of the WHO Accelerator Platform for Novel TB Regimens will be held on Thursday, 8 May 2025, from 14.00 to 15.30 (CET). Main...

The WHO released comprehensive guidelines for TB this week and shared important new updates to treatment options for MDR-TB. In...